Comparison

CCRF-CEM cells

Item no. C0003001
Manufacturer Addexbio
Amount One Frozen vial
Category
Type Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Adams, M., Efferth, T., and Bauer, R. Activity-guided isolation of scopoletin and isoscopoletin, the inhibitory active principles towards CCRF-CEM leukaemia cells and multi-drug resistant CEM/ADR5000 cells, from Artemisia argyi. Planta Med, 72: 862-864, 2006.
2.Anderson, A. B. and Arriaga, E. A. Subcellular metabolite profiles of the parent CCRF-CEM and the derived CEM/C2 cell lines after treatment with doxorubicin. J Chromatogr B Analyt Technol Biomed Life Sci, 808: 295-302, 2004.
3.Henrich, S., Crossett, B., and Christopherson, R. I. Differentially expressed nuclear proteins in human CCRF-CEM, HL-60, MEC-1 and Raji cells correlate with cellular properties. Proteomics Clin Appl, 1: 1252-1265, 2007.
4.Jow, G. M., Wu, Y. C., Guh, J. H., and Teng, C. M. Armepavine oxalate induces cell death on CCRF-CEM leukemia cell line through an apoptotic pathway. Life Sci, 75: 549-557, 2004.
5.Kong, Y., Ma, W., Liu, X., Zu, Y., Fu, Y., Wu, N., Liang, L., Yao, L., and Efferth, T. Cytotoxic activity of curcumin towards CCRF-CEM leukemia cells and its effect on DNA damage. Molecules, 14: 5328-5338, 2009.
6.Zu, Y., Liu, X., Fu, Y., Shi, X., Wu, N., Yao, L., and Efferth, T. Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage. Planta Med, 75: 1134-1140, 2009.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Available
Description

Disease:

Acute lymphoblastic leukemia

Origin:

Lymphoblast

Species:

Homo sapiens

Tissue:

Blood

Morphology:

Lymphoblast

Properties:

Suspension

Cytogenic data:

CCRF-CEM cells were derived from the peripheral blood buffy coat of a child (CEM) with acute lymphoblastic leukemia who had originally presented with lymphosarcoma

Patient:

Female, Caucasian, 4 yrs of age

Medium:

RPMI1640 + 10% FBS

Subculture:

Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 2 to 3 X 105 viable cells/ml. Maintain cell density between 1 to 2 X 106 viable cells/ml.

Medium Renewal:

Add fresh medium (20% to 30% by volume) every 2 to 3 days.

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO

Biosafety Level:

I

Sterility:

Bacteria: Negative

Yeast: Negative

Mycoplasma: Negative

Pathogens:

HIV: Negative

Hepatitis B: Negative

Hepatitis C: Negative

Isoenzymes:

ADA, 1; ES-D, 1; G6PD, B ; GLO-I, 1; PEP-D, 1; PGD, C; PGM1, 1 ; PGM3, 0

DNA Profile (STR):

Amelogenin: X ; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 10, 13; D5S818: 12, 13; D7S820: 9, 13; THO1: 6, 7; TPOX: 8; vWA: 17, 19

Related cells by Organ:

CCRF-CEM

K562

LP-1

MOLM-13

RPMI-8226

U937

RAW 264.7

Storage condition
LN2
Manufacturers Category
Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: One Frozen vial
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close